EN
HI

Astrazeneca Pharma India Share price

ASTRAZEN

9033.5

8.00 (-0.09%)
NSE
BSE
Last updated on 9 Dec, 2025 | 15:31 IST
BUYSELL
Today's High

9140.00

Today's Low

8930.00

52 Week Low

6312.75

52 Week High

10691.00

The current prices are delayed, login to your account for live prices

Astrazeneca Pharma India Chart

Astrazeneca Pharma India Share Key Metrics

Volume
7839.00
Market Cap
22583.75 CR
LTQ@LTP
1@9033.50
ATP
9026.4
Var Margin
17.84 %
Circuit Range
7233.5-10849.5
Delivery %
40.64 %
Value
7.08 CR
ASM/GSM
No
Market Lot
1

Summary

At 9 Dec, 2025 | 15:31, Astrazeneca Pharma India share price stands at ₹9033.5, showing a 8.00% -0.09 for the day. The stock’s intraday movement has stayed between ₹8930.00 and ₹9140.00, while on a 52-week basis it has fluctuated from ₹6312.75 to ₹10691.00.
In terms of trading activity, Astrazeneca Pharma India has recorded a volume of 7839 shares, with a market capitalisation of ₹25000000. The stock’s Average Traded Price (ATP) stands at ₹902640, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1,903350. The stock operates within a circuit range of ₹7233.5-10849.5, with a Value of ₹7.08 CR. The Delivery Percentage for the day is 40.64%. Additionally, Astrazeneca Pharma India currently falls under the No framework, and trades with a market lot size of 1.

Astrazeneca Pharma India Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

36.18

Sector P/B

0.98

Sec. Div. Yield

0.56

Astrazeneca Pharma India Resistance and Support

Pivot 9498.67

Resistance

First Resistance

9636.34

Second Resistance

9862.17

Third Resistance

9999.84

Support

First Support

9272.84

Second Support

9135.17

Third Support

8909.34

Astrazeneca Pharma India Futures & Options

Data Not Found

Astrazeneca Pharma India Shareholding Pattern

View More
  • 2016-17
  • 2017-18
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

75%

Mutual Fund

5%

Insurance

0.19%

Foreign Institutional Investors

2.74%

Domestic Institutional Investors

0.06%

Retail

17.01%

Others

0%

Total Promoters
MAR '25
75%
JUN '25
75%
SEP '25
75%

Astrazeneca Pharma India Corporate Actions

DateAgenda
2025-11-07Quarterly Results
2025-08-14Quarterly Results
2025-05-30Audited Results & Dividend
2025-02-11Quarterly Results
2024-11-13Quarterly Results
2024-08-08Quarterly Results

Astrazeneca Pharma India News

AstraZeneca Pharma India Q2 results: Net profit declines 55% to Rs 12 cr

Nov 10 2021 01:15:35
Read More

About Astrazeneca Pharma India

NSE : 5610  
BSE : 506820  
ISIN : INE203A01020  

Astrazeneca Pharma India Management

NamePosition
Ms. Shilpa Divekar Nirula Chairperson & Independent Director
Mr. Praveen Rao Akkinepally Managing Director
View More

Astrazeneca Pharma India FAQs

The Buying Price of Astrazeneca Pharma India share is 9033.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Astrazeneca Pharma India stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Astrazeneca Pharma India, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Astrazeneca Pharma India shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Astrazeneca Pharma India shares is 0. Useful to assess the stock's value relative to its book value.

To assess Astrazeneca Pharma India’s valuation compare Sector P/E, P/B which are 36.18 & 0.98 with sector averages, along with growth rates and financial metrics.

The Market Cap of Astrazeneca Pharma India is 22583.75 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Astrazeneca Pharma India share price is 10691.00 & 6312.75. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Astrazeneca Pharma India belongs to the Healthcare sector.